Detection of minimal disease in patients with solid tumors

Journal of Hematotherapy and Stem Cell Research

Volumn 5, Issue 4, 1996, Pages 359-367

  Pantel, Klaus ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; COMPLEMENTARY DNA; CYTOKERATIN; MEMBRANE ANTIGEN; MESSENGER RNA; MONOCLONAL ANTIBODY; MUCIN; PROSTATE SPECIFIC ANTIGEN;

ARTICLE; AUTOGRAFT; BLOOD; BONE MARROW; EPITHELIUM TUMOR; HUMAN; IMMUNOCYTOCHEMISTRY; LYMPH NODE; MINIMAL RESIDUAL DISEASE; ONCOGENE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SOLID TUMOR; STEM CELL TRANSPLANTATION; TUMOR CELL; TUMOR SUPPRESSOR GENE;

ANTIBODIES, MONOCLONAL; ANTIGENS, NEOPLASM; BONE MARROW; CARCINOMA; HUMANS; LYMPH NODES; MELANOMA; NEOPLASM CIRCULATING CELLS; NEOPLASM METASTASIS; NEOPLASM PROTEINS; NEOPLASM STAGING; NEOPLASM, RESIDUAL; POLYMERASE CHAIN REACTION; RNA, NEOPLASM; TUMOR MARKERS, BIOLOGICAL;

EID: 0029758141     PISSN: 15258165     EISSN: None     Source Type: Journal    
DOI: 10.1089/scd.1.1996.5.359     Document Type: Article

References (98)

1. Passlick, B., Izbicki, J.R., Kubuschok, B. et al. Immunohistochemical assessment of individual tumor cells in lymph nodes of patients with non-small cell lung cancer. J. Clin. Oncol. 12:1827, 1994.
2. Liotta, L.A., Kleinerman, J. & Saidel, G.M. Quantitative relationships of intravascular tumor cells, tumor vessels, and pulmonary metastases following tumor implantation. Cancer Res. 34:997, 1974.
3. Moss, T.J. The risk of tumor cell contamination in peripheral blood stem cell collections. J. Hematother. 1:225, 1992.
4. Moss, T., Cairo, M., Santana, V., et al. Clonogenicity of circulating neuroblastoma cells: Implications regarding peripheral blood stem cell transplantation. Blood 83:3085, 1994.
5. Osborne, M., Wong, G., Asina, S., et al. Sensitivity of immunocytochemical detection of breast cancer cells in human bone marrow. Cancer Res. 51:2706, 1991.
6. Molino, A., Colombatti, M., Bonetti, F., et al. A comparative analysis of three different techniques for the detection of breast cancer cells in bone marrow. Cancer 67:1033, 1991.
7. -7. Proc. Natl. Acad. Sci. USA 92:537, 1995.
8. Pantel, K., Schlimok, G., Angstwurm, M., et al. Methodological analysis of immunocytochemical screening for disseminated epithelial tumor cells in bone marrow. J. Hematother. 3:165, 1994.
9. Schlimok, G., Funke, I., Pantel, K., et al. Micrometastatic tumor cells in bone marrow of patients with gastric cancer: Methodological aspects of detection and prognostic significance. Eur. J. Cancer 27:1461, 1991.
10. Mansi, J.L., Easton, D., Berger, U., et al. Bone marrow micrometastases in primary breast cancer: Prognostic significance after 6 years' follow-up. Eur. J. Cancer 27:1552, 1991.
11. Diel, I.J., Kaufmann, M., Goerner, R., et al. Detection of tumor cells in bone marrow of patients with primary breast cancer: A prognostic factor for distant metastasis. J. Clin. Oncol. 10:1534, 1992.
12. Riesenberg, R., Oberneder, R., Kriegmair, M., et al. Immunocytochemical double staining of cytokeratin and prostate specific antigen in individual prostatic tumor cells. Histochemistry 99:61, 1993.
13. Schlimok, G., Funke, I., Holzmann, B., et al. Micrometastatic cancer cells in bone marrow: In vitro detection with anti-cytokeratin and in vivo labeling with anti-17-1A monoclonal antibodies. Proc. Natl. Acad. Sci. USA 84:8672, 1987.
14. Pantel, K. Detection, monitoring and characterization of micrometastatic carcinoma cells: Implications for autologous stem cell transplantation. In Recent Advances in Hematopoietic Stem Cell Transplantation - Clinical Progress, New Technologies and Gene Therapy. UCSD Cancer Center Press, San Diego, ISHAGE-Meeting Proceedings, 1994, p. 1.
15. Redding, H.W., Coombes, R.C., Monagham, P., et al. Detection of micrometases in patients with primary breast cancer. Lancet 2:1271, 1983.
16. Schlimok, G., Pantel, K. & Riethmüller, G. Autologous stem cell transplantation in breast cancer: Does stem cell mobilization treatment mobilize tumor cells? Blood 82:653, 1993.
17. Eschwège, P., Dumas, F., Blanchet P., et al. Haematogenous dissemination of prostatic epithelial cells during radical prostatectomy. Lancet 346:1528, 1995.
18. Denis, M.G., Tessier, M.-H., Dréno, B., et al. Circulating micrometastases following oncological surgery. Lancet 347:913, 1996.
19. Fidler, I.J. & Hart, I.R. Biological diversity in metastatic neoplasms: Origin and implications. Science 217:998, 1982.
20. Weiss, L. A mechanism for the destruction of cancer cells in the microvasculature. In Metastasis: Basic Research and Its Clinical Applications. eds. Rabes, H., Peters, P.E. & Munk, K., Karger, Basel, 1992, p. 242.
21. Gribben, J.G., Neuberg, D., Barber, M., et al. Detection of residual lymphoma cells by polymerase chain reaction in peripheral blood is significantly less predictive for relapse than detection in bone marrow. Blood 83:3800, 1994.
22. Ross, A.A., Cooper, B.W., Lazarus, H.M., et al. Detection and viability of tumor cells in peripheral blood stem cell collections from breast cancer patients using immunocytochemical and clonogenic assay techniques. Blood 82:2605, 1993.
23. Douer, D., Chaiwun, B., Glaspy, J., et al. Analysis of peripheral blood progenitor cell (PBPC) harvests for occult breast cancer micrometastases using a sensitive immunohistochemical method. Proc. Am. Assoc. Clin. Oncol. 12:62, 1993.
24. Sharp, J.G., Kessinger, A., Vaughan, W.P., et al. Detection and clinical significance of minimal tumour cell contamination of peripheral stem cell harvests. Int. J. Cell Cloning 10 (Suppl. 1):92, 1992.
25. Vredenburgh, J., Bast, R.C. & DeSombre, K. Detection of breast cancer cells in the bone marrow of peripheral blood in patients with >10 positive nodes. Proc. Am. Assoc. Cancer Res. 34:190, 1993.
26. Brugger, W., Bross, K.J., Glatt, M., et al. Mobilization of tumor cells and hematopoietic progenitor cells into peripheral blood of patients with solid tumors. Blood 83:636, 1994.
27. Brenner, M.K., Rill, D.R., Moen, R.C., et al. Gene-marking to trace origin of relapse after autologous bone-marrow transplantation. Lancet 341:85, 1993.
28. Rill, D.R., Santana, V.M., Roberts, W.M., et al. Direct demonstration that autologous bone marrow transplantation for solid tumors can return a multiplicity of tumorigenic cells. Blood 84:380, 1994.
29. Mykelbust, A., Godal, A., Juell, S., et al. Comparison of two antibody-based methods for elimination of breast cancer cells from human bone marrow. Cancer Res. 54:209, 1994.
30. s adenovirus selectively induces apoptosis in cancer cells but not in normal bone marrow cells. Proc. Natl. Acad. Sci. USA 92:11024, 1995.
31. Passos-Coelho, J., Ross, A., Davis, J., et al. Bone marrow micrometastases in chemotherapy-responsive advanced breast cancer: Effect of ex vivo purging with 4-hydroperoxycyclophosphamide. Cancer Rs. 54:2366, 1994.
32. Shpall, E., Jones, R., Beaman, S., et al. Transplantation of enriched CD34-positive autologous marrow into breast cancer patients following high-dose chemotherapy: Influence of CD34-positive peripheral-blood progenitors and growth factors on engraftment. J. Clin. Oncol. 12:28, 1994.
33. International Breast Cancer Study Group, I. Prognostic importance of occult axillary lymph node micrometastases from breast cancers. Lancet 335:1565, 1990.
34. Domagala, W., Bedner, E. & Chosia, M. Keratin-positive reticulum cells in fine needle aspirates and touch imprints of hyperplastic lymph nodes. Acta Cytol. 36:241, 1991.
35. Chen, Z.L., Perez, S., Holmes, E.X., et al. Frequency and distribution of occult micrometastases in lymph nodes of patients with non-small-cell lung carcinoma. J. Natl. Cancer Inst. 85:493, 1993.
36. Cutait, R., Alves, V.A., Lopes, L.C., et al. Restaging of colorectal cancer based on the identification of lymph node micrometastases through immunoperoxidase staining of CEA and cytokeratins. Dis. Colon Rectum 34:917, 1991.
37. De Mascarel, I., Bonichon, F., Coindre, J.M., et al. Prognostic significance of breast cancer axillary lymph node micrometastases assesed by two special techniques: Reevaluation with longer follow-up. Br. J. Cancer 66:523, 1992.
38. Deguchi, T., Doi, T., Ehara, H., et al. Detection of micrometastatic prostate cancer cells in lymph nodes by reverse transcriptase-polymerase chain reaction. Cancer Res. 53:5350, 1993.
39. Stosiek, P., Kasper, M., Karsten, U., et al. Detection of cancer metastases in regional lymph nodes: Comparative histological and immunohistological investigations with a broad-range anticytokeratin monoclonal antibody A45-B/B3. Neoplasma 38:43, 1991.
40. Latza, U., Niedobitek, G. & Schwarting, R. Ber-EP4: New monoclonal antibody which distinguishes epithelial from mesothelia. J. Clin. Pathol. 43:213, 1990.
41. Mansi, J.L., Mesker, W.E., McDonnell, T., et al. Automated screening for micrometastases in bone marrow smears. J. Immunol. Methods 112:105, 1988.
42. Hoechtlen-Vollmar, W., Gruber, R., Bodenmüller, H., et al. Occult epithelial tumor cells detected in bone marrow by an enzyme immunoassay specific for cytokeratin-19. Submitted.
43. Gribben, J.G., Freedman, A.S. & Neuberg, D. Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation of B-cell lymphoma. N. Engl. J. Med. 325:1525, 1991.
44. Bos, I.L. Ras oncogenes in human cancer: A review. Cancer Res. 49:4682, 1989.
45. Harris, C.C. & Hollstein, M. Clinical implications of the p53 tumor-suppressor gene. N. Engl. J. Med. 329:1318, 1993.
46. Tada, M., Omata, M., Kawai, S.H., et al. Detection of ras gene mutations in pancreatic juice and peripheral blood of patients with pancreatic adenocarcinoma. Cancer Res. 53:2472, 1993.
47. Hayashi, N., Arakawa, H., Nagase, H., et al. Genetic diagnosis identifies occult lymph node metastases undetectable by the histopathological method. Cancer Res. 54:3853, 1994.
48. Hayashi, N., Ito, I., Yanagisawa, A., et al. Genetic diagnosis of lymph-node metastasis in colorectal cancer. Lancet 345:1257, 1995.
49. Schoenfeld, A., Luqmani, Y., Smith, D., et al. Detection of breast cancer micrometastases in axillary lymph nodes by using polymerase chain reaction. Cancer Res. 54:2986, 1994.
50. Datta, Y.H., Adams, P.T. & Drobyski, W.R. Sensitive detection of occult breast cancer by the reverse-transcriptase polymerase chain reaction. J. Clin. Oncol 12:475, 1994.
51. Krismann, M., Todt, B., Schröder, J., et al. Low specificity of cytokeratin 19 reverse transcriptase-polymerase chain reaction analyses for detection of hematogenous lung cancer dissemiantion. J. Clin. Oncol. 13:2769, 1995.
52. Zippelius, A., Honold, G., Kufer, P., et al. Potential and limitations of RT-PCR for detection of isolated carcinoma cells in bone marrow. Exp. Hematol. 23:764, 1995.
53. Smith, M.R., Biggar, S. & Hussain, M. Prostate-specific antigen messenger RNA is expressed in non-prostate cells: Implications for detection of micrometastases. Cancer Res. 55:2640, 1995.
54. Monne, M., Croce, C.M., Yu, H., et al. Molecular characterization of prostate-specific antigen messenger RNA expressed in breast tumors. Cancer Res. 54:6344, 1994.
55. Moreno, J.G., Croce, C.M., Fischer, R., et al. Detection of hematogenous micrometastasis in patients with prostate cancer. Cancer. Res. 52:6110, 1992.
56. Wood, D.P., Banks, E.R., Humphries, S., et al. Identification of micrometatases in patients with prostate cancer. J. Urol. 151:303, 1994.
57. Seiden, M.V., Kantoff, P.W., Krithivas, K., et al. Detection of circulating tumor cells in men with localized prostate cancer. J. Clin. Oncol. 12:2634, 1994.
58. Israeli, R.S., Miller, W.H. Jr., Su, S.L. et al. Sensitive nested reverse transcription polymerase chain reaction detection of circulating prostatic tumor cells: Comparison of prostate-specific membrane antigen and prostate-specific antigen-based assays. Cancer Res. 54:6306, 1994.
59. Katz, A.E., Olsson, C.A., Raffo, A.J., et al. Molecular staging of prostate cancer with the use of an enhanced reverse transcriptase-PCR assay. Urology 43:765, 1994.
60. Katz, A.E., de Vries, B.S., Begg, M.D., et al. Enhanced reverse transcriptase-polymerase chain reaction for prostate-specific antigen as an indicator of true pathologic stage in patients with prostate cancer. Cancer 75:1642, 1995.
61. Jaakkola, S., Vornamen, T., Leinonen, J., et al. Detection of prostatic cells in peripheral blood: Correlation with serum concentrations of prostate-specific antigen. Clin. Chem. 41:182, 1995.
62. Galvan, B., Christopoulos, T.K. & Diamandis, E.P. Detection of prostate-specific antigen mRNA by reverse transcription polymerase chain reaction and time-resolved fluorometry. Clin. Chem. 41:1705, 1995.
63. Pantel, K., Dickmanns, A., Zippelius, A., et al. Establishment of micrometastatic carcinoma cell lines: A novel source of tumor cell vaccines. J. Natl. Cancer Inst. 87:1162, 1995.
64. Miller, J.I., Ahmann, P.R. & Drach, G.W. The clinical usefulness of serum prostate-specific antigen after hormonal therapy of metastatic prostate cancer. J. Urol 147:956, 1992.
65. Heston, W.D.W. Detection of hematogenous dissemination of prostatic cancer by RT-PCR with primers specific for prostate-specific membrane antigen. Clin. Chem. 41:1687, 1995.
66. Loric, S., Dumas, F., Eschwege, P., et al. Enhanced detection of hematogenous circulating prostatic cells in patients with prostate adenocarcinoma by using nested reverse transcription polymerase chain reaction assay based on prostate-specific membrane antigen. Clin. Chem. 41:1698, 1995.
67. Gerhard, M., Juhl, H., Kalthoff, H., et al. Specific detection of carcinoembryonic antigen-expressing tumor cells in bone marrow aspirates by polymerase chain reaction. J. Clin. Oncol. 12:725, 1994.
68. Mori, M., Mimori, K., Inoue, H., et al. Detection of cancer micrometastases in lymph nodes by reverse transcriptase-polymerase chain reaction. Cancer Res. 55:3417, 1995.
69. Noguchi, S., Aihara, T., Nakamori, S., et al. The detection of breast carcinoma micrometastases in axillary lymph nodes by means of reverse transcriptase-polymerase chain reaction. Cancer 74:1595, 1994.
70. Smith, B., Selby, P., Southgate, J., et al. Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reaction. Lancet 338:1227, 1991.
71. Brossart, P., Schmier, J.-W., Krüger, S., et al. A polymerase chain reaction-based semiquantitative assessment of malignant melanoma cells in peripheral blood. Cancer Res. 55:4065, 1995.
72. Hoon, D.S.B., Wang, Y., Dale, P.S., et al. Detection of occult melanoma cells in blood with a multiple-marker polymerase chain reaction assay. J. Clin. Oncol. 13:2109, 1995.
73. Hermanek, P. What's new in TNM? Pathol. Res. Pract. 190:97, 1994.
74. Lindemann, F., Schlimok, G., Dirschedl, P., et al. Prognostic significance of micrometastatic tumour cells in bone marrow of colorectal cancer patients. Lancet 340:685, 1992.
75. Pantel, K., Schlimok, G., Braun, S., et al. Differential expression of proliferation-associated molecules in individual micrometastatic carcinoma cells. J. Natl. Cancer Inst. 85:1419, 1993.
76. Pantel, K., Schlimok, G., Kutter, D., et al. Frequent down-regulation of major histocompatibility class I antigen expression on individual micrometastatic carcinoma cells. Cancer Res. 51:4712, 1991.
77. Pantel, K., Schlimok, G., Angstwurm, M., et al. Early metastasis of human solid tumors: Expression of cell adhesion molecules. Ciba Foundation Symposium 189a: 157, 1995.
78. Pallavicini, M.G., Cher, M.L., Bowers, E.E., et al. Chromosomal aneusomies in prostate cancer marrow micrometastases. Proc. Am. Assoc. Cancer Res. 36:69, 1995.
79. Müller, P. & Schlimok, G. Detection of Her-2/neu amplification in bone marrow micrometastatic cells by fluorescence in situ hybridization (FISH). Onkologie 17 (Suppl. 2):101, 1994.
80. Trümper, L.H., Brady, G., Bagg, A., et al. Single-cell analysis of Hodgkin and Reed-Sternberg cells: Molecular heterogeneity of gene expression and p53 mutations. Blood 81:3097, 1993.
81. Joshi, S., Novak, D., Messbarger, L., et al. Levels of detection of tumor cells in human bone marrow with or without prior culture. Bone Marrow Transplant. 6:179, 1990.
82. Sloane, J.P. Molecules and micrometastases. Lancet 345:1255, 1995.
83. Harbeck, N., Untch, M., Pache, L., et al. Tumour cell detection in the bone marrow of breast cancer patients at primary therapy: Results of a 3-year median follow-up. Br. J. Cancer 69:566, 1994.
84. Cote, R.J., Rosen, P.P., Lesser, M.L., et al. Prediction of early relapse in patients with operable breast cancer by detection of occult bone marrow micrometastases. J. Clin. Oncol. 9:1749, 1991.
85. Schlimok, G., Lindemann, F., Holzmann, K., et al. Prognostic significance of tumor cells detected in bone marrow of breast cancer patients: A multivariate analysis. Onkologie 17 (Suppl 2):128, 1994.
86. Juhl, H., Stritzel, M., Wroblewski, A., et al. Immunocytological detection of micrometastatic cells: Comparative evaluation of findings in the peritoneal cavity and the bone marrow of gastric, colorectal and pancreatic cancer patients. Int. J. Cancer 57:330, 1994.
87. Jauch, K., Heiss, M.M., Grützner, U., et al. The prognostic significance of early disseminated tumor cells in bone marrow of patients with gastric cancer. J. Clin. Oncol. In press.
88. Thorban, S., Roder, J.D., Pantel, K., et al. Epithelial tumour cells in bone marrow of patients with pancreatic carcinoma detected by immunocytochemical staining. Eur. J. Cancer 32A:363, 1996.
89. Thorban, S., Roder, J.D., Nekarda, H., et al. Immunocytochemical detection of disseminated tumor cells in bone marrow of patients with esophageal cancer. J. Natl. Cancer Inst. In press.
90. Stahel, R.A., Mabry, M., Skarin, A.T., et al. Detection of bone marrow metastasis in small cell lung cancer by monoclonal antibody. J. Clin. Oncol. 3:455, 1985.
91. Humblet, Y., Canon, J.L., Sekhavat, M., et al. Detection of small-cell lung cancer bone marrow metastases by immunofluorescence. Pathobiology 36:25, 1988.
92. Pantel, K., Izbicki, J., Passlick, B., et al. Frequency and prognostic significance of isolated tumour cells in bone marrow of patients with non-small-cell lung cancer without overt metastases. Lancet 347:649, 1996.
93. Cote, R.J., Beattie, E.J., Chaiwun, B., et al. Detection of occult bone marrow micrometastases in patients with operable lung carcinoma. Ann. Surg. 222:415, 1995.
94. Oberneder, R., Kriegmair, M., Pantel, K., et al. Prognostic relevance of micrometastatic tumor cells in bone marrow of patients with genitourinary tract tumors. J. Urol. 151:413, 1994.
95. Pantel, K., Aignherr, C., Köllermann, J., et al. Immunocytochemical detection of isolated tumor cells in bone marrow of patients with untreated stage C prostatic cancer. Eur. J. Cancer 31A:1627, 1995.
96. Oberneder, R., Riesenberg, R., Kriegmair, M., et al. Immunocytochemical detection and phenotypic characterization of micrometastatic tumor cells in bone marrow of patients with prostate cancer. Urol. Res. 22:3, 1994.
97. Mansi, J.L., Berger, U., Wilson, P., et al. Detection of tumor cells in bone marrow of patients with prostatic carcinoma by immunocytochemical techniques. J. Urol. 139:545, 1988.
98. Gath, H.J., Heissler, E., Hell, B., et al. Immunocytologic detection of isolated tumor cells in bone marrow of patients with squamous cell carcinomas of the head and neck region. Int. J. Oral Maxillofac. 24:351, 1995.